Late breaking trials of 2016 in structural heart disease and peripheral artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA

Catheter Cardiovasc Interv. 2017 May;89(6):1093-1099. doi: 10.1002/ccd.27004. Epub 2017 Mar 17.

Authors

Ehrin J Armstrong¹, Adnan K Chhatriwalla², Molly Szerlip³, Rajesh V Swaminathan⁴, Rajan A G Patel⁵

Affiliations

¹ University of Colorado and Denver VA Medical Center, Denver, Colorado.
² Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
³ The Heart Hospital Baylor Plano, Plano, Texas.
⁴ Division of Cardiology, Duke University Medical Center and the Duke Clinical Research Institute, Durham, North Carolina.
⁵ Ochsner Medical Center, New Orleans, Louisiana.

PMID: 28303672
DOI: 10.1002/ccd.27004

No abstract available

MeSH terms

Clinical Trials as Topic*
Heart Diseases / diagnosis
Heart Diseases / physiopathology
Heart Diseases / therapy*
Humans
Peripheral Arterial Disease / diagnosis
Peripheral Arterial Disease / physiopathology
Peripheral Arterial Disease / therapy*
Societies, Medical
Treatment Outcome